This test is most useful if any of these apply to you.
You sneeze around cats, your eyes water, your chest tightens, but a basic cat allergy test came back unimpressive. Or maybe you tested positive for cat allergy and want to know exactly which proteins your immune system is reacting to, because that answer changes how well immunotherapy will work and how much your dog exposure might be feeding the problem.
Fel d 7 (Felis domesticus allergen 7) is one of several cat proteins your immune system can target. Testing the IgE antibody your blood makes against this specific protein helps explain why your symptoms persist, why you sometimes react to dogs too, and whether you fall into a more complex allergic profile that standard cat extract testing tends to miss.
The test measures the amount of a specific antibody (IgE) in your blood that binds to Fel d 7, a small protein in the lipocalin family that cats shed in saliva and on their fur. IgE is the antibody class your body produces when it treats a harmless substance as a threat. When you encounter that substance again, the IgE attaches to immune cells called mast cells and basophils, which then release the chemicals that produce sneezing, itching, wheezing, and rashes.
Fel d 7 is one of about a dozen known cat allergen proteins. Fel d 1 is the most famous and most abundant, but Fel d 7 is increasingly recognized as a meaningful player. In published cohorts of cat-allergic patients, sensitization to Fel d 7 specifically has been reported in roughly 38 to 46 percent of cat-sensitized patients, depending on the population studied. (A separate, often-cited finding that more than 65 percent of patients with cat-related respiratory symptoms are sensitized refers to the combined recognition of Fel d 1, Fel d 4, and Fel d 7 together, not to Fel d 7 alone.) In one Swedish cohort of cat-sensitized patients, 46 percent had Fel d 7 IgE with a median level of 2.76 kUA/L, a unit that simply means the concentration of allergen-specific antibody in your blood.
A traditional cat allergy test mixes many cat proteins together and reports one combined IgE result. That works for a yes-or-no answer about cat allergy, but it tells you almost nothing about which specific proteins are driving your reaction or whether your sensitivity to dogs is part of the same problem. Breaking the response apart into individual components gives you a more honest picture.
In studies of cat-sensitized patients, panels combining several major cat components (such as Fel d 1, Fel d 2, and Fel d 4) have identified close to all symptomatic patients, with reported sensitivity around 98 percent for one such combination. Adding Fel d 7 to the picture helps round out the molecular profile, since cumulative IgE to a broader cat component set, including Fel d 7, is what tracks most closely with complex cat allergy phenotypes.
Fel d 7 is a frequent finding in people with cat-related respiratory disease. Sensitization to multiple cat components, including Fel d 7, is linked to a higher likelihood of asthma and rhinoconjunctivitis on cat exposure. In a study of early teens, less abundant cat allergens like Fel d 7 had higher relevance to asthma than their lower abundance would suggest, because they generated less of a protective IgG4 response.
A study of nineteen-year-olds in northern Sweden found that high-titer IgE antibodies to cat and dog allergens were strongly associated with asthma diagnosis, severity, and persistence, even in people who did not live with a pet. This means a positive Fel d 7 result is not just a curiosity. It correlates with the kind of allergic profile most likely to produce ongoing respiratory disease.
This is where Fel d 7 earns its keep clinically. Fel d 7 belongs to a protein family called lipocalins, and it cross-reacts with a dog lipocalin called Can f 1. IgE that binds Fel d 7 often binds Can f 1 too. Published work describes a moderate correlation between IgE levels to the two proteins, along with shared epitopes and bidirectional inhibition in laboratory experiments. In practical terms, this means your reaction to cats and your reaction to dogs may be two faces of the same immune mistake.
Some people may test negative on standard cat dander extract but positive for Fel d 7. One plausible explanation is that exposure to dogs primed an immune response to lipocalins that then cross-reacted with the cat version, although this specific scenario has not been directly demonstrated in isolation and should be treated as a hypothesis. Without component testing, this pattern is invisible. With it, possible sources of the problem become easier to investigate.
In a small study of 100 adults with atopic dermatitis using a multi-allergen panel, about half had high or very high IgE to Fel d 7. People with cat-related skin symptoms tend to have broader IgE responses, including to Fel d 7. The cumulative sum of IgE to several cat components, including Fel d 7, identifies patients with the most complex cat allergy phenotypes, meaning more symptoms across more body systems.
A few situations can distort how a single Fel d 7 IgE result should be read:
You may see a positive Fel d 7 with a negative or low cat dander extract, and wonder how both can be true. One likely resolution is that cat dander extract is dominated by Fel d 1, the most abundant cat protein, and commercial extracts are known to vary substantially in their Fel d 7 content. If your immune system has chosen to react primarily to a less abundant lipocalin like Fel d 7, the diluted signal in a whole-extract assay can fall below the cutoff while the component-specific test picks it up. This kind of pattern is what component testing was designed to reveal.
A single IgE measurement captures a moment in your immune profile. Levels can shift with seasonal exposure, time spent around pets, and the gradual evolution of your allergic phenotype, especially in children and young adults. One cat-asthma study with repeated measures over 28 days noted low intra-subject variability for IgE, suggesting reasonable short-term stability, but longer-term changes are real.
If you are considering allergen immunotherapy, planning a major lifestyle change like adopting a pet, or watching whether childhood sensitization patterns are evolving, repeat Fel d 7 testing every one to two years gives you a trajectory rather than a snapshot. After starting immunotherapy or making sustained environmental changes, retest at six to twelve months to see how your antibody profile is responding.
A positive result by itself is data, not a verdict. The next step is to combine it with your symptoms, your exposure history, and other cat components. If you have not already, test for Fel d 1 (the dominant cat allergen) and Fel d 4 (another lipocalin) to build a full picture. Add a dog component panel, particularly Can f 1, to map out the cross-reactivity story. A skin prick test remains a useful complement, because for cat allergy it is often more sensitive than any single component IgE.
If Fel d 7 is your main positive component but Fel d 1 is negative, you may not be a strong candidate for standard cat allergen immunotherapy, which is mostly standardized to Fel d 1 and has its strongest evidence in Fel d 1-monosensitized patients. That is an important conversation to have with an allergist. If multiple cat components are positive alongside dog components, polysensitization is driving your symptoms, and a broader treatment plan is appropriate. If your results combined with symptoms point to asthma, working with a pulmonologist alongside an allergist usually produces the best long-term outcome.
Cat (Fel d 7) IgE is best interpreted alongside these tests.
Cat (Fel d 7) IgE is included in these pre-built panels.